Cindy Boer

Vitamin K Antagonist Anticoagulants and Osteoarthritis | 147 3.2 23. Rieder, M.J., et al., Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose. N Engl J Med, 2005. 352(22): p. 2285-93. 24. Teichert, M., et al., Dependency of phenprocoumon dosage on polymorphisms in the VKORC1, CYP2C9, and CYP4F2 genes. Pharmacogenet Genomics, 2011. 21(1): p. 26-34. 25. Roncaglioni, M.C., et al., Warfarin-induced accumulation of vitamin K-dependent proteins. Com- parison between hepatic and non-hepatic tissues. Biochem Biophys Res Commun, 1983. 114(3): p. 991-7. 26. Thijssen, H.H. and M.J. Drittij-Reijnders, Vitamin K status in human tissues: tissue-specific accumu- lation of phylloquinone and menaquinone-4. Br J Nutr, 1996. 75(1): p. 121-7. 27. Price, P.A. and Y. Kaneda, Vitamin K counteracts the effect of warfarin in liver but not in bone. Thromb Res, 1987. 46(1): p. 121-31. 28. Sato, T., et al., Difference in the metabolism of vitamin K between liver and bone in vitamin K-defi- cient rats. Br J Nutr, 2002. 87(4): p. 307-14. 29. Hara, K., M. Kobayashi, and Y. Akiyama, Comparison of inhibitory effects of warfarin on gamma-car- boxylation between bone and liver in rats. J Bone Miner Metab, 2005. 23(5): p. 366-72. 30. Ulrich, M.M., et al., Vitamin K is no antagonist for the action of warfarin in rat osteosarcoma UMR 106. Thromb Res, 1988. 50(1): p. 27-32. 31. Gomez-Outes, A., et al., Discovery of anticoagulant drugs: a historical perspective. Curr Drug Dis- cov Technol, 2012. 9(2): p. 83-104. 32. Mekaj, Y.H., et al., New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events. Ther Clin Risk Manag, 2015. 11: p. 967-77. 33. Kim, I.S., et al., Non-vitamin K antagonist oral anticoagulants have better efficacy and equivalent safety compared to warfarin in elderly patients with atrial fibrillation: A systematic review and meta-analysis. J Cardiol, 2018. 72(2): p. 105-112. 34. Haas, S., et al., Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF. Am Heart J, 2019. 213: p. 35-46. 35. Veronese, N., et al., Association of Osteoarthritis With Increased Risk of Cardiovascular Diseases in the Elderly: Findings From the Progetto Veneto Anziano Study Cohort. Arthritis Rheumatol, 2016. 68(5): p. 1136-44. 36. Wang, H., et al., Osteoarthritis and the risk of cardiovascular disease: a meta-analysis of observa- tional studies. Sci Rep, 2016. 6: p. 39672.